5y chart: Since Nov. 2020, lows are higherFor what's it worth, and technical analysis aside, one thing is visually strinking when looking at the 5y chart; lows are always higher since the low of Nov. 2, 2020. Nov. 2, 2020 ... 0.125$ Nov. 1. 2021 ... 0.185$ April 10, 2023 ... 0.245$ And 2 of the 3 highs are higher: Feb. 15, 2021 ... 0.315$ March 14, 2022 ... 0.47$ Jan. 16, 2023 ... 0.39$ The Feb. 15, 2021 (0.315$) and March 14, 2022 (0.47$) would point to 0.75$ when extrapolating them. That could prove a real possibility if the upcoming data brings positive visibility. We'll see in few weeks if that's really what the chart were telling us. For sure, there's a resistance @0.40$ though.
But all this points to a.new reality; a new level of maturity for the company, as we evolve toward commercialization (50% into a pivotal phase 2, booth at AUA, applying for FDA Breakthrough Therapy, 2023-2024 discussions with big pharmas, etc ...).